By proceeding, you agree to our Terms of Use and Privacy Policy.
Fina Biosolutions LLC is a privately held research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for prevention of life-threatening diseases. Fina has patented novel techniques to conjugate, purify, and manufacture conjugates using its proprietary chemistry to create complex conjugate vaccines. The technology is currently licensed by leading vaccine manufacturers in both Europe and Asia, including GlaxoSmithKline for marketed vaccines Synflorix™ Menitorix™, Nimenrix™, The Serum Institute of India Ltd., The Chengdu Institute of Biological Products and others. Fina Bosolutions also manufactures E. coli expressed CRM197 conjugate vaccine carrier portein.
13-15 November 2023
Vaccines Summit 2023 is an esteemed international conference organized by Scientia Meetings, bringing together participants from around the world. This highly anticipated event is scheduled to take place from November 13th to 15th, 2023, under the co
Event Ended
USA
Paid
Boston